Isoxazolines: A Novel Chemotype Highly Effective on Ectoparasites

ChemMedChem - Tập 11 Số 3 - Trang 270-276 - 2016
Tina Weber1, Paul M. Selzer2,3,4
1Marie Curie Initial Training Network “ParaMet” Institute of Infection, Immunity and Inflammation University of Glasgow Glasgow UK
2Boehringer Ingelheim Animal Health GmbH Binger Straße 173 55216 Ingelheim am Rhein Germany
3Universität Tübingen Interfakultäres Institut für Biochemie Tübingen Germany
4Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Faculty of Biomedical & Life Sciences, University of Glasgow, Glasgow, UK

Tóm tắt

AbstractEfficient control of arthropod ectoparasite infestations has a long‐standing history in the agriculture and veterinary sectors, aiming to decrease the parasite burden of affected crops and animals. Ligand‐gated chloride channels (LGCCs) modulated by γ‐aminobutyric acid (GABA) and glutamate have been identified as suitable molecular targets, and several classes of potent parasiticides have been devised. Due to the increase in cross‐resistance and decreased development of new chemical entities, an urgent need for new parasiticides or prevention schemes has emerged. In the last decade, an innovative isoxazoline chemotype appears to offer promise for inhibiting LGCCs with a new mode of action and distinct binding site from that of historical agents. Considerable efforts have focused on optimizing the antiparasitic activity of isoxazolines and may provide the potential for future human use.

Từ khóa


Tài liệu tham khảo

10.1007/s13593-012-0105-x

10.1016/j.ijpara.2010.04.005

Ware G. W., 2004, in The Pesticide Book

10.1038/nrmicro887

10.1146/annurev-ento-120811-153645

10.3109/10799899109066401

10.1007/978-3-642-59549-3_2

10.1289/ehp.01109s1113

10.1006/pest.1993.1035

10.1016/j.pestbp.2009.07.008

10.1021/jm00184a014

10.1126/science.6308762

Barragry T. B., 1987, Can. Vet. J., 28, 512

10.1146/annurev.en.36.010191.000515

10.2174/138920112800399095

10.1016/0006-2952(89)90473-5

10.1016/0742-8413(90)90073-I

10.1002/arch.940220104

10.1006/taap.2001.9154

10.1038/nature04708

10.3389/fnmol.2012.00060

10.1021/bk-1995-0591.ch017

10.1016/0742-8413(93)90138-B

T.Mita Y.Kudo T.Mizukoshi H.Hotta K.Maeda S.Takii(Nissan Chemical Ind. Ltd.) Int. PCT Pub. No. WO 2004018410 A1 2004.

10.1021/tx500520w

T.Mita T.Kikuchi T.Mizukoshi M.Yaosaka M.Komoda(Nissan Chemical Ind. Ltd.) Int. PCT Pub. No. WO 2005085216 A1 2005.

10.1016/j.bbrc.2009.11.131

10.1016/j.bmcl.2013.03.031

10.1016/j.vetpar.2014.02.020

NADA 141-406 US Food and Drug Administration:www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/UCM377867.pdf(accessed August 7 2015).

J. K.Long T. P.Selby M.Xu(Du Pont) Int. PCT Pub. No. WO 2009045999 A1 2009.

T.Mita T.Kikuchi T.Mizukoshi M.Yaosaka M.Komoda(Nissan Chemical Ind. Ltd.) Int. PCT Pub. No. WO 2005085216 A1 2005.

NADA 141-426 US Food and Drug Administration www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/UCM399075.pdf(accessed August 7 2015).

10.1016/j.ibmb.2013.11.009

A. R.Heckeroth J.Lutz C.Mertens H.Williams H.Zoller T.Mita(Intervet Int. BV) Int. PCT Pub. No. WO 2009024541 A2 2009.

10.1038/363449a0

10.1021/bk-1995-0591.ch012

10.1146/annurev.ento.45.1.449

10.1002/arch.940260106

10.1038/nature06717

10.1016/j.ibmb.2013.02.002

Molecular Operating Environment (MOE) 2013.08; Chemical Computing Group Inc. 1010 Sherbooke Street West Suite #910 Montréal QC H3A 2R7 (Canada) 2015.

10.1016/0048-3575(91)90060-Y

10.1016/0048-3575(92)90025-U

10.1074/jbc.271.33.20187

10.1017/S0031182005008218

10.1074/jbc.R112.406280

10.1038/nature10139

10.1021/tx400055p

10.1021/jf4050809

10.1051/parasite/2014045

10.1016/j.vetpar.2014.02.024

S.Nanchen(Novartis AG) Int. PCT Pub. No. WO 2014090918 A1 2014.

D.Billen N. A. L.Chubb M.Curtis S. D. W.Greenwood S.Menon T.Stuk V. A.Vaillancourt(Pfizer Inc.) Int. PCT Pub. No. WO 2012120399 A1 2012.

European Medicines Agency:www.ema.europa.eu/(accessed October 18 2015).

T. L. McTier N. Chubb M. P. Curtis L. Hedges G. A. Inskeep C. S. Knauer S. Menon B. Mills A. Pullins E. Zinser D. J. Woods D. P. Meeus at25thInternational Conference of the World Association for the Advancement of Veterinary Parasitology Liverpool (UK) 2015 Ref. O090/0101.

L. Hedges W. Collard D. Merritt A. Fielder S. Grover J. Boucher S. Mahabir at25thInternational Conference of the World Association for the Advancement of Veterinary Parasitology Liverpool (UK) 2015 Ref. P1A216/0519.

Z.An L.Chen S.Chen J. M.Defauw S. D.Holmstrom P.Hu C.Tang W. H.White W.Wu Y.Zhang(Eli Lilly & Co.) Int. PCT Pub. No. WO 2012155676 A1 2012.

T.Akama T. W.Balko J. M.Defauw J.Plattner W. H.White J. R.Winkle Y-K.Zhang Y.Zhou(Eli Lilly & Co. Anacor Pharmaceuticals Inc.) Int. PCT Pub. No. WO 2013078071 A1 2013.

Geary T. G., 2009, Drug Discovery in Infectious Diseases: Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates

Thông tin
Thông tin xuất bản

ChemMedChem

Tập 11 Số 3

270-276

Thông tin tác giả